N
Naser Javahertrash
Researcher at Iran University of Medical Sciences
Publications - 4
Citations - 253
Naser Javahertrash is an academic researcher from Iran University of Medical Sciences. The author has contributed to research in topics: Primary immunodeficiency & Epidemiology. The author has an hindex of 4, co-authored 4 publications receiving 197 citations. Previous affiliations of Naser Javahertrash include Yazd University.
Papers
More filters
Journal ArticleDOI
Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry.
Asghar Aghamohammadi,Payam Mohammadinejad,Hassan Abolhassani,Babak Mirminachi,Masoud Movahedi,Mohammad Gharagozlou,Nima Parvaneh,Vaheid Zeiaee,Bahram Mirsaeedghazi,Zahra Chavoushzadeh,Alireza Mahdaviani,Mahboubeh Mansouri,Sedigheh Yousefzadegan,Bahareh Sharifi,Fariborz Zandieh,Ehsan Hedayat,Ali Nadjafi,Roya Sherkat,Behzad Shakerian,Mahnaz Sadeghi-Shabestari,Reza Farid Hosseini,Farahzad Jabbari-Azad,Hamid Ahanchian,Fatemeh Behmanesh,Mohammadreza Zandkarimi,Afshin Shirkani,Taher Cheraghi,Abbas Fayezi,Iraj Mohammadzadeh,Reza Amin,Soheila Aleyasin,Mojgan Moghtaderi,Javad Ghaffari,Saba Arshi,Naser Javahertrash,Mohammad Nabavi,Mohammad Hassan Bemanian,A.R. Shafiei,Najmedin Kalantari,Akefeh Ahmadiafshar,Hossein Ali Khazaei,Lida Atarod,Nima Rezaei +42 more
TL;DR: Registration of Iranian PID patients increased the awareness of medical community of Iran and developed diagnostic and therapeutic techniques across more parts of the country and better estimation of PID in Iran is presented.
Journal ArticleDOI
Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis
Hassan Abolhassani,Hassan Abolhassani,Hassan Abolhassani,Fatemeh Kiaee,Fatemeh Kiaee,Marzieh Tavakol,Zahra Chavoshzadeh,Seyed Alireza Mahdaviani,Tooba Momen,Reza Yazdani,Reza Yazdani,Gholamreza Azizi,Sima Habibi,Sima Habibi,Mohammad Gharagozlou,Masoud Movahedi,Amir Ali Hamidieh,Nasrin Behniafard,Mohammamd Nabavi,Mohammad Hassan Bemanian,Saba Arshi,Rasol Molatefi,Roya Sherkat,Afshin Shirkani,Reza Amin,Soheila Aleyasin,Reza Faridhosseini,Farahzad Jabbari-Azad,Iraj Mohammadzadeh,Javad Ghaffari,Alireza Shafiei,Arash Kalantari,Mahboubeh Mansouri,Mehrnaz Mesdaghi,Delara Babaie,Hamid Ahanchian,Maryam Khoshkhui,Habib Soheili,Mohammad Hossein Eslamian,Taher Cheraghi,Abbas Dabbaghzadeh,Abbas Dabbaghzadeh,Mahmoud Tavassoli,Rasoul Nasiri Kalmarzi,Seyed Hamidreza Mortazavi,Sara Kashef,Hossein Esmaeilzadeh,Javad Tafaroji,Abbas Khalili,Fariborz Zandieh,Mahnaz Sadeghi-Shabestari,Sepideh Darougar,Fatemeh Behmanesh,Hedayat Akbari,Mohammadreza Zandkarimi,Farhad Abolnezhadian,Abbas Fayezi,Mojgan Moghtaderi,Akefeh Ahmadiafshar,Behzad Shakerian,Vahid Sajedi,Behrang Taghvaei,Mojgan Safari,Marzieh Heidarzadeh,Babak Ghalebaghi,Seyed Mohammad Fathi,Behzad Darabi,Saeed Bazregari,Nasrin Bazargan,Morteza Fallahpour,Alireza Khayatzadeh,Naser Javahertrash,Bahram Bashardoust,Mohammad Ali Zamani,Azam Mohsenzadeh,Sarehsadat Ebrahimi,Samin Sharafian,Ahmad Vosughimotlagh,Mitra Tafakoridelbari,Maziar Rahimi,Parisa Ashournia,Anahita Razaghian,Arezou Rezaei,Arezou Rezaei,Setareh Mamishi,Nima Parvaneh,Nima Parvaneh,Nima Rezaei,Nima Rezaei,Lennart Hammarström,Asghar Aghamohammadi,Asghar Aghamohammadi +91 more
TL;DR: Among the genetically different categories of PID patients, the diagnostic rate was highest in defects in immune dysregulation and lowest in predominantly antibody deficiencies and mutations in the MEFV gene were the most frequent genetic disorder in this cohort.
Journal ArticleDOI
Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort.
Reza Yazdani,Hassan Abolhassani,Hassan Abolhassani,Fatemeh Kiaee,Sima Habibi,Gholamreza Azizi,Marzieh Tavakol,Zahra Chavoshzadeh,Seyed Alireza Mahdaviani,Tooba Momen,Mohammad Gharagozlou,Masoud Movahedi,Amir Ali Hamidieh,Nasrin Behniafard,Mohammamd Nabavi,Mohammad Hassan Bemanian,Saba Arshi,Rasol Molatefi,Roya Sherkat,Afshin Shirkani,Reza Amin,Soheila Aleyasin,Reza Faridhosseini,Farahzad Jabbari-Azad,Iraj Mohammadzadeh,Javad Ghaffari,Alireza Shafiei,Arash Kalantari,Mahboubeh Mansouri,Mehrnaz Mesdaghi,Delara Babaie,Hamid Ahanchian,Maryam Khoshkhui,Habib Soheili,Mohammad Hossein Eslamian,Taher Cheraghi,Abbas Dabbaghzadeh,Mahmoud Tavassoli,Rasoul Nasiri Kalmarzi,Seyed Hamidreza Mortazavi,Sara Kashef,Hossein Esmaeilzadeh,Javad Tafaroji,Abbas Khalili,Fariborz Zandieh,Mahnaz Sadeghi-Shabestari,Sepideh Darougar,Fatemeh Behmanesh,Hedayat Akbari,Mohammadreza Zandkarimi,Farhad Abolnezhadian,Abbas Fayezi,Mojgan Moghtaderi,Akefeh Ahmadiafshar,Behzad Shakerian,Vahid Sajedi,Behrang Taghvaei,Mojgan Safari,Marzieh Heidarzadeh,Babak Ghalebaghi,Seyed Mohammad Fathi,Behzad Darabi,Saeed Bazregari,Nasrin Bazargan,Morteza Fallahpour,Alireza Khayatzadeh,Naser Javahertrash,Bahram Bashardoust,Mohammad Ali Zamani,Azam Mohsenzadeh,Sarehsadat Ebrahimi,Samin Sharafian,Ahmad Vosughimotlagh,Mitra Tafakoridelbari,Maziar Rahim,Parisa Ashournia,Anahita Razaghian,Arezou Rezaei,Ashraf Samavat,Setareh Mamishi,Hossein Ali Khazaei,Javad Mohammadi,Babak Negahdari,Nima Parvaneh,Nima Rezaei,Vassilios Lougaris,Silvia Giliani,Alessandro Plebani,Hans D. Ochs,Lennart Hammarström,Asghar Aghamohammadi +90 more
TL;DR: First presentations in most patients with Immunodeficiency, Centromeric instability, and Facial dysmorphism were respiratory complications, whereas first presentations in patients with lipopolysaccharides-responsive beige-like anchor deficiency were nonrespiratory complications, highlighting similarities and differences in the clinical and genetic spectrum of the most common PAD-associated gene defects.
National Consensus on Diagnosis and Management Guidelines for Primary Immunodeficiency
Hassan Abolhassani,Marzieh Tavakol,Zahra Chavoshzadeh,Seyed Alireza Mahdaviani,Tooba Momen,Reza Yazdani,Gholamreza Azizi,Masoud Movahedi,Amir Ali Hamidieh,Nasrin Behniafard,Mohammamd Nabavi,Saba Arshi,Mohammad Hassan Bemanian,Morteza Fallahpour,Sima Shokri,Rasol Molatefi,Roya Sherkat,Afshin Shirkani,Reza Amin,Soheila Aleyasin,Reza Faridhosseini,Farahzad Jabbari-Azad,Iraj Mohammadzadeh,Javad Ghaffari,Alireza Shafiei,Arash Kalantari,Mahboubeh Mansouri,Mehrnaz Mesdaghi,Delara Babaie,Hamid Ahanchian,Maryam Khoshkhui,Habib Soheili,Mohammad Hossein Eslamian,Taher Cheraghi,Abbas Dabbaghzadeh,Mahmoud Tavassoli,Rasoul Nasiri Kalmarzi,Seyed Hamidreza Mortazavi,Sara Kashef,Hossein Esmaeilzadeh,Javad Tafaroji,Abbas Khalili,Fariborz Zandieh,Mahnaz Sadeghi-Shabestari,Sepideh Darougar,Fatemeh Behmanesh,Hedayat Akbari,Mohammadreza Zandkarimi,Farhad Abolnezhadian,Abbas Fayezi,Mojgan Moghtaderi,Akefeh Ahmadiafshar,Behzad Shakerian,Vahid Sajedi,Behrang Taghvaei,Mojgan Safari,Marzieh Heidarzadeh,Babak Ghalehbaghi,Seyed Mohammad Fathi,Behzad Darabi,Saeed Bazregari,Nasrin Bazargan,Alireza Khayatzadeh,Naser Javahertrash,Bahram Bashardoust,Mohammad Ali Zamani,Azam Mohsenzadeh,Sarehsadat Ebrahimi,Samin Sharafian,Ahmad Vosughimotlagh,Mitra Tafakoridelbari,Maziar Rahimi,Parisa Ashournia,Anahita Razaghian,Fatemeh Aghaeimeybodi,Setareh Mamishi,Nima Parvaneh,Nima Rezaei,Asghar Aghamohammadi +78 more
TL;DR: This PID guideline is summarized based on the importance of different clinical complications and the level of medical authority visiting those at the first line and for each complication, appropriate interventions are mentioned to improve the approach.